Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

Global Gastroesophageal Reflux Disease Therapeutics Market Report 2024

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025 – By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), By Distribution Channel (Hospital Pharmacy, Drug Stores, General Stores, Supermarkets), By Application (Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis) – Market Size, Trends, And Global Forecast 2025-2034

Name: Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

Proud Members Of

Gastroesophageal Reflux Disease Therapeutics Market Definition

Gastroesophageal reflux disease (GERD) therapeutics is a medication for chronic medical illness characterized by the upward movement of stomach contents into the esophagus that causes heartburn and regurgitation. The therapeutics are used to neutralize and reduce the production of stomach acid to maintain optimal pH in the gut and prevent the passage of fluids back into the stomach that cause acid reflux.

The main gastroesophageal reflux disease therapeutics are branded and generic. Branded refers to any medical substance that may only be supplied according to a prescription order from a physician or other authorized prescriber under state or federal rules and these drugs are used to treatment of gastroesophageal reflux disease to eliminate symptoms and allow esophageal healing. The various drug classes are antacids, proton pump inhibitors, histamine blockers, pro-kinetic agents, and others that are distributed using different channels such as hospital pharmacies, drug stores, general stores, and supermarkets. These are applied in Crohn’s disease, gastroesophageal reflux disease (GERD), and ulcerative colitis.

Gastroesophageal Reflux Disease Therapeutics Market Segmentation

The gastroesophageal reflux disease therapeutics market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class

3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Super markets

4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis

Subsegments:

1) By Branded: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Antacids, Coating Agents

2) By Generic: Generic Proton Pump Inhibitors (PPIs), Generic H2-Receptor Antagonists, Generic Antacids, Generic Coating Agents

Gastroesophageal Reflux Disease Therapeutics Market Size and growth rate 2025 to 2029: Graph

Gastroesophageal Reflux Disease Therapeutics Market Size 2025 And Growth Rate

The gastroesophageal reflux disease therapeutics market size has grown steadily in recent years. It will grow from $5.93 billion in 2024 to $6.14 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to changing lifestyles and dietary habits, aging population, increased awareness and diagnosis, prevailing stressful lifestyles, rise in obesity rates

Gastroesophageal Reflux Disease Therapeutics Market Growth Forecast

The gastroesophageal reflux disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in demand for novel therapies, growing geriatric population, personalized medicine approaches, focus on non-pharmacological interventions, emergence of biologics and innovative therapies. Major trends in the forecast period include alternative therapies and mind-body practices, expanded research into gut health, advent of patient-centric care models, targeted marketing for gerd awareness, integration of digital health tools.

Book your 30 minutes free consultation with our research experts

Gastroesophageal Reflux Disease Therapeutics Market Driver: Surge In Gastroesophageal Reflux Disease Anticipated To Drive The Growth Of The Gastroesophageal Reflux Disease Therapeutics Market

The prevalence of gastroesophageal reflux disease is expected to propel the growth of the gastroesophageal reflux disease therapeutics market moving forward. Gastroesophageal reflux disease is a chronic condition characterized by the backflow of stomach acid into the esophagus, causing symptoms such as heartburn, regurgitation, and potential complications. The gastroesophageal reflux disease (GERD) therapeutics help in reducing and managing the symptoms of acid reflux by neutralizing the pH of the gut, controlling inflammation, and improving esophageal function. For instance, in September 2022, according to the article published by WebMed, a US-based online publisher of news and information about human health, more than 60 million American adults suffer heartburn at least once a month, and more than 15 million suffer daily. Furthermore, in July 2022, statistics shared by the National Library of Medicine, a US-based federal medical library, GERD is one of the most often diagnosed digestive illnesses in the United States, with a 20% prevalence, resulting in a significant economic burden in direct and indirect expenditures as well as a negative impact on quality of life. Therefore, the prevalence of gastroesophageal reflux disease is expected to drive the growth of the gastroesophageal reflux disease therapeutics market.

Gastroesophageal Reflux Disease Therapeutics Market Driver: Self-Medication Trends Propel The Gastroesophageal Reflux Disease Therapeutics Market

The adoption of self-medication is significantly contributing to the growth of the gastroesophageal reflux disease therapeutics market going forward. Self-medication is the practice of using drugs or other substances to treat a medical condition without consulting a healthcare professional. Self-medication plays a significant role in identifying and avoiding trigger foods, managing stress, and quitting smoking, which can significantly improve GERD symptoms. For instance, in May 2022, according to a survey of 170 people by Lippincott Williams & Wilkins, a US-based provider of professional health information, around 57.7% reported practicing self-medication, and 34.7% felt a lack of need to visit a medical practitioner in 2022. Therefore, the adoption of remote working will drive the gastroesophageal reflux disease therapeutics market.

Global Gastroesophageal Reflux Disease Therapeutics Market Major Players

Major companies operating in the gastroesophageal reflux disease therapeutics market include Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, Medtronic PLC, GlaxoSmithKline plc, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, bioMerieux SA, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., EndoGastric Solutions, RaQualia Pharma Inc, TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited

Global Gastroesophageal Reflux Disease Therapeutics Market Trend: Innovative Medications To Reshape The Gastroesophageal Reflux Disease Therapeutics Market

Product innovations are the key trend gaining popularity in the gastroesophageal reflux disease therapeutics market. Major companies operating in the gastroesophageal reflux disease therapeutics market are focusing on innovative medications to sustain their position in the market. For instance, in November 2023, Phathom Pharmaceuticals, a US-based biopharmaceutical company, launched VOQUEZNA (vonoprazan), a potassium-competitive acid blocker, approved for the healing and maintenance of all grades of erosive esophagitis, as well as for alleviating heartburn associated with both erosive and non-erosive GERD. Clinical trials showed remarkable outcomes, with a healing rate of 93% in patients treated with the 20 mg dosage, compared to 85% for the standard proton pump inhibitor (PPI) lansoprazole.

Global Gastroesophageal Reflux Disease Therapeutics Market Trend: Advanced Diagnostic Solutions For Gastroesophageal Reflux Disease Therapeutics

Major companies operating in the gastroesophageal reflux disease therapeutics market are concentrating towards developing innovative systems such as wireless pH-capsule reflux testing systems. Wireless pH-capsule reflux testing systems are medical devices designed for the diagnosis and monitoring of gastroesophageal reflux disease (GERD) and related conditions. For instance, in April 2023, Laborie Medical Technologies Corp., a US-based medical testing equipment manufacturing company, announced the launch of alpHaONE system. It is a wireless pH-capsule reflux testing system that is specifically designed to diagnose gastroesophageal reflux disease (GERD). The system offers up to 96 hours of data monitoring, provides accurate and reliable data. alpHaONE presents a distinctive solution featuring an ergonomic and compact design, enlarged buttons that are easy to press, and a fail-safe capsule delivery system designed to safeguard the patients oesophagus.

Gastroesophageal Reflux Disease Therapeutics Market Merger And Acquisition: Evonik And Phathom Pharmaceuticals Join Forces For Gerd Drug Manufacturing

In October 2022, Evonik Industries AG, a Germany-based specialty chemicals company, partnered with Phathom Pharmaceuticals. Through the agreement, Evonik aims to produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in USA and Germany. Phathom Pharmaceuticals is a US-based biopharmaceutical firm focused on innovative medicines for stomach acid-related disorders offering gastroesophageal reflux disease drugs.

Regional Outlook For The Global Gastroesophageal Reflux Disease Therapeutics Market

North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastroesophageal reflux disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastroesophageal Reflux Disease Therapeutics Market?

The gastroesophageal reflux disease (GERD) therapeutics market consists of sales of amino-salicylates (5-ASA), corticosteroids, immunomodulators, antibiotics, biologics, and dopamine receptor antagonist. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gastroesophageal Reflux Disease Therapeutics Industry?

The gastroesophageal reflux disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides gastroesophageal reflux disease therapeutics market statistics, including gastroesophageal reflux disease therapeutics industry global market size, regional shares, competitors with a gastroesophageal reflux disease therapeutics market share, detailed gastroesophageal reflux disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the gastroesophageal reflux disease therapeutics industry. This gastroesophageal reflux disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastroesophageal Reflux Disease Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$6.14 billion
Revenue Forecast In 2034	$7.89 billion
Growth Rate	CAGR of 6.5% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Branded, Generic 2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class 3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets 4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis Subsegments: 1) By Branded: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Antacids, Coating Agents 2) By Generic: Generic Proton Pump Inhibitors (PPIs), Generic H2-Receptor Antagonists, Generic Antacids, Generic Coating Agents
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, Medtronic PLC, GlaxoSmithKline plc, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, bioMerieux SA, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., EndoGastric Solutions, RaQualia Pharma Inc, TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gastroesophageal Reflux Disease Therapeutics Market Characteristics

3. Gastroesophageal Reflux Disease Therapeutics Market Trends And Strategies

4. Gastroesophageal Reflux Disease Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Gastroesophageal Reflux Disease Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Gastroesophageal Reflux Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gastroesophageal Reflux Disease Therapeutics Market Growth Rate Analysis

5.4. Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gastroesophageal Reflux Disease Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gastroesophageal Reflux Disease Therapeutics Total Addressable Market (TAM)

6. Gastroesophageal Reflux Disease Therapeutics Market Segmentation

6.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Branded

Generic

6.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antacids

Proton Pump Inhibitors

Histamine Blockers

Pro-Kinetic Agents

Other Drug Classes

6.3. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Drug Stores

General Stores

Supermarkets

6.4. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Crohn’s Disease

Gastroesophageal Reflux Disease (GERD)

Ulcerative Colitis

6.5. Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Proton Pump Inhibitors (PPIs)

H2-Receptor Antagonists

Antacids

Coating Agents

6.6. Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic Proton Pump Inhibitors (PPIs)

Generic H2-Receptor Antagonists

Generic Antacids

Generic Coating Agents

7. Gastroesophageal Reflux Disease Therapeutics Market Regional And Country Analysis

7.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market

8.1. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastroesophageal Reflux Disease Therapeutics Market

9.1. China Gastroesophageal Reflux Disease Therapeutics Market Overview

9.2. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastroesophageal Reflux Disease Therapeutics Market

10.1. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastroesophageal Reflux Disease Therapeutics Market

11.1. Japan Gastroesophageal Reflux Disease Therapeutics Market Overview

11.2. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastroesophageal Reflux Disease Therapeutics Market

12.1. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastroesophageal Reflux Disease Therapeutics Market

13.1. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastroesophageal Reflux Disease Therapeutics Market

14.1. South Korea Gastroesophageal Reflux Disease Therapeutics Market Overview

14.2. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastroesophageal Reflux Disease Therapeutics Market

15.1. Western Europe Gastroesophageal Reflux Disease Therapeutics Market Overview

15.2. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastroesophageal Reflux Disease Therapeutics Market

16.1. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastroesophageal Reflux Disease Therapeutics Market

17.1. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastroesophageal Reflux Disease Therapeutics Market

18.1. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastroesophageal Reflux Disease Therapeutics Market

19.1. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastroesophageal Reflux Disease Therapeutics Market

20.1. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market

21.1. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market Overview

21.2. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastroesophageal Reflux Disease Therapeutics Market

22.1. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastroesophageal Reflux Disease Therapeutics Market

23.1. North America Gastroesophageal Reflux Disease Therapeutics Market Overview

23.2. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastroesophageal Reflux Disease Therapeutics Market

24.1. USA Gastroesophageal Reflux Disease Therapeutics Market Overview

24.2. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastroesophageal Reflux Disease Therapeutics Market

25.1. Canada Gastroesophageal Reflux Disease Therapeutics Market Overview

25.2. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastroesophageal Reflux Disease Therapeutics Market

26.1. South America Gastroesophageal Reflux Disease Therapeutics Market Overview

26.2. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastroesophageal Reflux Disease Therapeutics Market

27.1. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastroesophageal Reflux Disease Therapeutics Market

28.1. Middle East Gastroesophageal Reflux Disease Therapeutics Market Overview

28.2. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastroesophageal Reflux Disease Therapeutics Market

29.1. Africa Gastroesophageal Reflux Disease Therapeutics Market Overview

29.2. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape And Company Profiles

30.1. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape

30.2. Gastroesophageal Reflux Disease Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Gastroesophageal Reflux Disease Therapeutics Market Other Major And Innovative Companies

31.1. Medtronic PLC

31.2. GlaxoSmithKline plc

31.3. Eisai Co. Ltd.

31.4. Takeda Pharmaceutical Company Limited

31.5. bioMerieux SA

31.6. Teva Pharmaceutical Industries

31.7. Dr. Reddy's Laboratories Ltd.

31.8. Amneal Pharmaceuticals LLC

31.9. CHEPLAPHARM Arzneimittel GmbH

31.10. Daewoong Pharmaceutical Co. Ltd

31.11. Ironwood Pharmaceuticals Inc.

31.12. Sebela Pharmaceuticals Inc.

31.13. Camber Pharmaceuticals Inc.

31.14. Sun Pharmaceutical Industries Ltd.

31.15. EndoGastric Solutions

32. Global Gastroesophageal Reflux Disease Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease Therapeutics Market

34. Recent Developments In The Gastroesophageal Reflux Disease Therapeutics Market

35. Gastroesophageal Reflux Disease Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Gastroesophageal Reflux Disease Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Johnson and Johnson Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Sanofi S.A. Financial Performance

Table 81: AstraZeneca plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gastroesophageal Reflux Disease Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Johnson and Johnson Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Sanofi S.A. Financial Performance

Figure 81: AstraZeneca plc Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the gastric cancer drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-asthmatic and copd drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dry eye medication market research report 2022 with industry size, share, segments and market growth

Real-Time Location Systems (RTLS) Global Market Report 2025 – By Component (Hardware, Software, Service), By Technology (RFID, Wi-Fi, Ultra-wideband (UWB), Bluetooth Low Energy (BLE), Ultrasound, Infrared (IR), GPS, Other Technologies), By Application (Inventory Or Asset Tracking And Management, Personnel Or Staff Locating And Monitoring, Access Control And Security, Environmental Monitoring, Supply Chain Management And Operational Automation Or Visibility, Other Applications), By End Use Industry (Transportation And Logistics, Healthcare, Retail, Manufacturing And Processing, Other End User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rail Asset Management Global Market Report 2025 – By Solution (Asset Performance Management, Analytics, Asset Planning & Scheduling, Security, Workforce Management, Other Solutions), By Services (Professional Services, Managed Services), By Deployment Mode (Cloud, On-premises), By Application (Rolling Stock, Infrastructure) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Wireless Intercom Global Market Report 2025 – By Type (Outdoor Intercom, Indoor Intercom), By Technology (Wi-Fi Band, Radio Frequency), By Radio Frequency (Single, Dual, Multi), By Application (Small And Medium Enterprises (SMEs), Large Enterprises, Hospitality, Security And Surveillance, Transportation And Logistics, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Sonar Systems Global Market Report 2025 – By Product (Hull-Mounted Sonar, Stern-Mounted Sonar, Dipping Sonar, Sonobuoy ), By Installation (Fixed, Deployable ), By Acoustic Frequency (Ultrasonic, Infrasonic), By Application (Anti-Submarine Warfare, Port Security, Mine Detection and Countermeasure Systems, Search and Rescue, Navigation, Diver Detection, Seabed Terrain Investigation, Scientific) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Commercial Services Global Market Report 2025 – By Type (Office Administrative Services, Facilities Support Services, Employment Services, Business Support Services, Travel Arrangement And Reservation Services, Waste Management And Remediation Services, Investigation And Security Services, Services to Buildings And Dwellings, Other Support Services), By Mode (Online, Offline), By Service Type (Hard Services, Soft Services, Other Services) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Facilities Support Services Global Market Report 2025 – By Type (Maintenance Services, Security And Guard Services, Reception Services, Other Facilities Support Services), By Mode (Online, Offline), By Deployment Type (On-Premise, Cloud) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Investigation And Security Services Global Market Report 2025 – By Type (Investigation, Guard, And Armored Car Services, Security Systems Services), By Deployment Type (On-Premise, Cloud), By Application (IPS And IDS, Distributed Denial of Services (DDoS), Unified Threat Management (UTM), Secured Information And Event Management (SIEM), Endpoint Security, Firewall management) – Market Size, Trends, And Global Forecast 2025-2034

View Report

IOT Sensors Global Market Report 2025 – By Product Type (Temperature sensors, Pressure sensors, Humidity sensors, Flow sensors, Accelerometers, Magnetometers, Gyroscopes, Inertial sensors, Image sensors, Other Product Types), By Application (Building Automation, Industrial Application, Automotive Application, Healthcare Application, Retailing & Logistics Application, Security Application, Agriculture Application, Other Applications), By End-user Industry (Healthcare, Automotive and Transportation, Manufacturing / Industrial, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Gastroesophageal Reflux Disease Therapeutics market?

How will the Gastroesophageal Reflux Disease Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Gastroesophageal Reflux Disease Therapeutics industry going forward?

The Gastroesophageal Reflux Disease Therapeutics market major growth driver - Surge In Gastroesophageal Reflux Disease Anticipated To Drive The Growth Of The Gastroesophageal Reflux Disease Therapeutics Market. For further insights on the Gastroesophageal request a sample here

What is the forecast market size or the forecast market value of the Gastroesophageal Reflux Disease Therapeutics market?

The Gastroesophageal Reflux Disease Therapeutics market size has grown strongly in recent years. The gastroesophageal reflux disease therapeutics market size has grown steadily in recent years. It will grow from $5.93 billion in 2024 to $6.14 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to changing lifestyles and dietary habits, aging population, increased awareness and diagnosis, prevailing stressful lifestyles, rise in obesity rates The gastroesophageal reflux disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in demand for novel therapies, growing geriatric population, personalized medicine approaches, focus on non-pharmacological interventions, emergence of biologics and innovative therapies. Major trends in the forecast period include alternative therapies and mind-body practices, expanded research into gut health, advent of patient-centric care models, targeted marketing for gerd awareness, integration of digital health tools. For further insights on the Gastroesophageal Reflux Disease Therapeutics market, request a sample here

How is the Gastroesophageal Reflux Disease Therapeutics market segmented?

The gastroesophageal reflux disease therapeutics market covered in this report is segmented –
1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Super markets
4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis Subsegments:
1) By Branded: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Antacids, Coating Agents
2) By Generic: Generic Proton Pump Inhibitors (PPIs), Generic H2-Receptor Antagonists, Generic Antacids, Generic Coating Agents For further insights on the Gastroesophageal Reflux Disease Therapeutics market, request a sample here

Which region has the largest share of the Gastroesophageal Reflux Disease Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Gastroesophageal Reflux Disease Therapeutics market, request a sample here.

Who are the major players in the Gastroesophageal Reflux Disease Therapeutics market?

What are the key trends in the Gastroesophageal Reflux Disease Therapeutics market?

Major trends in the Gastroesophageal Reflux Disease Therapeutics market include Innovative Medications To Reshape The Gastroesophageal Reflux Disease Therapeutics Market. For further insights on the Gastroesophageal Reflux Disease Therapeutics market, request a sample here.

What are the major opportunities in the Gastroesophageal Reflux Disease Therapeutics market? What are the strategies for the Gastroesophageal Reflux Disease Therapeutics market?

For detailed insights on the major opportunities and strategies in the Gastroesophageal Reflux Disease Therapeutics market, request a sample here.

How does the Gastroesophageal Reflux Disease Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Gastroesophageal Reflux Disease Therapeutics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Gastroesophageal Reflux Disease Therapeutics industry?

For detailed insights on the mergers and acquisitions in the Gastroesophageal Reflux Disease Therapeutics industry, request a sample here.

What are the key dynamics influencing the Gastroesophageal Reflux Disease Therapeutics market growth? SWOT analysis of the Gastroesophageal Reflux Disease Therapeutics market.

For detailed insights on the key dynamics influencing the Gastroesophageal Reflux Disease Therapeutics market growth and SWOT analysis of the Gastroesophageal Reflux Disease Therapeutics industry, request a sample here.